Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Portacci A, Campisi R, Buonamico E, Nolasco S, Pelaia C, Crimi N, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Scichilone N, Pelaia G, Crimi C, Carpagnano GE. Portacci A, et al. Among authors: crimi n. ERJ Open Res. 2023 Oct 30;9(5):00419-2023. doi: 10.1183/23120541.00419-2023. eCollection 2023 Sep. ERJ Open Res. 2023. PMID: 37908397 Free PMC article.
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis R, Harrison TW, Chanez P, Menzella F, Philteos G, Cosio BG, Lugogo NL, de Luiz G, Burden A, Adlington T, Keeling N, Kwiatek J, Garcia Gil E; ANDHI Study Investigators. Louis R, et al. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1759-1770.e7. doi: 10.1016/j.jaip.2023.03.009. Epub 2023 Mar 21. J Allergy Clin Immunol Pract. 2023. PMID: 36948488 Free article.
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study.
Campisi R, Nolasco S, Pelaia C, Impellizzeri P, D'Amato M, Portacci A, Ricciardi L, Scioscia G, Crimi N, Scichilone N, Foschino Barbaro MP, Pelaia G, Carpagnano GE, Vatrella A, Crimi C; Southern Italy Network on Severe Asthma Therapy. Campisi R, et al. Among authors: crimi n. J Clin Med. 2023 Jun 9;12(12):3953. doi: 10.3390/jcm12123953. J Clin Med. 2023. PMID: 37373648 Free PMC article.
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
Nolasco S, Portacci A, Campisi R, Buonamico E, Pelaia C, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Crimi N, Scichilone N, Pelaia G, Carpagnano GE, Crimi C. Nolasco S, et al. Among authors: crimi n. Front Immunol. 2023 Jun 30;14:1204444. doi: 10.3389/fimmu.2023.1204444. eCollection 2023. Front Immunol. 2023. PMID: 37457743 Free PMC article.
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis.
Pelaia C, Crimi C, Benfante A, Caiaffa MF, Campisi R, Candia C, Carpagnano GE, Carrieri I, D'Amato M, Detoraki A, Barbaro MPF, Lombardo N, Macchia L, Maglio A, Minenna E, Nolasco S, Paglino G, Papia F, Ricciardi L, Scichilone N, Scioscia G, Spadaro G, Tondo P, Uletta Lionetti S, Valenti G, Vatrella A, Crimi N, Pelaia G. Pelaia C, et al. Among authors: crimi n. Respirology. 2024 Oct;29(10):869-879. doi: 10.1111/resp.14767. Epub 2024 Jun 7. Respirology. 2024. PMID: 38847185 Free article.
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study.
Crimi C, Nolasco S, Noto A, Maglio A, Quaranta VN, Di Bona D, Scioscia G, Papia F, Caiaffa MF, Calabrese C, D'Amato M, Pelaia C, Campisi R, Vitale C, Ciampo L, Dragonieri S, Minenna E, Massaro F, Gallotti L, Macchia L, Triggiani M, Scichilone N, Valenti G, Pelaia G, Foschino Barbaro MP, Carpagnano GE, Vatrella A, Crimi N; Southern Italy Network on Severe Asthma Therapy. Crimi C, et al. Among authors: crimi n. J Allergy Clin Immunol Pract. 2024 Aug 27:S2213-2198(24)00852-3. doi: 10.1016/j.jaip.2024.08.033. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39197750 Free article.
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab.
Di Bona D, Bilancia M, Crimi C, Daddato M, Benfante A, Caiaffa MF, Calabrese C, Campisi R, Nolasco S, Carpagnano GE, D'Amato M, Pelaia C, Pelaia G, Maglio A, Scichilone N, Scioscia G, Spadaro G, Triggiani M, Carrieri I, Valenti G, Vatrella A, Macchia L, Crimi N. Di Bona D, et al. Among authors: crimi n. Clin Exp Allergy. 2024 Oct 10. doi: 10.1111/cea.14584. Online ahead of print. Clin Exp Allergy. 2024. PMID: 39390847
191 results